Walleye Capital’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$226K Buy
19,000
+11,800
+164% +$169K ﹤0.01% 3263
2025
Q4
$111K Buy
+7,200
New +$132K ﹤0.01% 3828
2025
Q3
Sell
-3,200
Closed -$71.1K 5068
2025
Q2
$71.1K Buy
+3,200
New +$71.1K ﹤0.01% 3918
2023
Q4
Sell
-1,500
Closed -$43.9K 5457
2023
Q3
$43.9K Buy
+1,500
New +$53.9K ﹤0.01% 4225

Other funds holding SGRY

Walleye Capital's SGRY Position: Q1 2026 in Review

Walleye Capital reduced its Surgery Partners (SGRY) stake by 99% in Q1 2026, selling an estimated $5.29M and leaving 3,162 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3962.

Walleye Capital first reported a position in SGRY in Q3 2021 and has held it in 12 quarters since. The position peaked at $16.1M in Q3 2024. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • Walleye Capital held 3,162 shares of Surgery Partners worth $37.7K as of Q1 2026.
  • Walleye Capital sold 368,833 Surgery Partners shares in Q1 2026, an estimated $5.29M.
  • Surgery Partners made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3962 holding.
  • Walleye Capital first reported a position in Surgery Partners in Q3 2021 and has held it in 12 quarters since.
  • Walleye Capital's Surgery Partners position peaked at $16.1M in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.